公开(公告)号：EP1937677A1

公开(公告)日：2008-07-02

申请号：EP06826157.7

申请日：2006-10-17

申请人： Acadia Pharmaceuticals Inc.

发明人： OLSSON, Roger ,  EK, Fredrik ,  OTTESEN, Lars, Korsgaard ,  BULOW, Anne ,  BURSTEIN, Ethan

IPC分类号： C07D419/12 ,  C07D267/20 ,  C07D245/06 ,  C07D225/08 ,  C07D295/18 ,  C07D337/14 ,  C07D281/16 ,  C07F7/08 ,  C07D419/04 ,  C07D417/04 ,  A61P25/00 ,  A61K31/5513 ,  A61K31/554 ,  A61K31/551

CPC分类号： C07D419/12 ,  C07D223/20 ,  C07D225/08 ,  C07D243/38 ,  C07D245/06 ,  C07D267/20 ,  C07D281/16 ,  C07D295/192 ,  C07D337/14 ,  C07D417/04 ,  C07D417/06 ,  C07D417/12 ,  C07D417/14 ,  C07D419/04

摘要： Disclosed herein is a compound of Formula (I). Also disclosed herein is a method of modulating the activity of a cannabinoid receptor using a compound of Formula (I). Furthermore, disclosed herein is a method of treating a disease or condition that would be alleviated, improved or prevented by administration of a compound that modulates a cannabinoid receptor comprising identifying a subject in need thereof and administering to said subject a therapeutically effective amount of a compound of Formula (I). Also disclosed herein are pharmaceutical compositions comprising a compound of Formula (I).